. 2017 Feb 14;6(3):129–138. doi: 10.1530/EC-17-0007
This work is licensed under a Table 1.
Demographic and baseline characteristics of TransCon GH and Omnitrope cohorts.
| Cohort 1 TransCon GH 0.02 mg/kg/week | Cohort 2 TransCon GH 0.04 mg/kg/week | Cohort 3 TransCon GH 0.08 mg/kg/week | Cohort 4 Omnitrope 0.04 mg/kg/week | |
|---|---|---|---|---|
| At screening | n = 10 | n = 10 | n = 9 | n = 8 |
| Male, female | 5, 5 | 4, 6 | 4, 5 | 5, 3 |
| Mean age (years) (s.d.) | 55.7 (12.6) | 45.9 (15.0) | 51.6 (18.1) | 44.0 (15.7) |
| Mean weight (kg) (s.d.) | 82.3 (19.8) | 79.6 (17.0) | 92.5 (20.5) | 74.7 (16.6) |
| Mean height (cm) (s.d.) | 171.7 (10.9) | 168.5 (11.4) | 172.7 (10.0) | 170.1 (12.9) |
| Mean BMI (kg/m2) (s.d.) | 27.6 (4.4) | 27.9 (4.4) | 30.7 (4.4) | 25.7 (4.4) |
| At Day 0 | n = 10 | n = 8 | n = 9 | n = 8 |
| Mean IGF-1 (ng/mL) (s.d.) | 41.9 (16.8) | 42.8 (26.9) | 42.6 (12.7) | 54.0 (25.6) |